Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XM01 versus epoetin beta in non-dialysis chronic renal failure anemia
2005-000142-37Phase 3Completed
- Sponsor
- BioGeneriX AG
- Start
- Apr 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Uraemic Anaemia and chronic kidney disease (CKD) comparing XM01 subcutaneous with epoetin beta subcutaneous (2 arms). Started Apr 2005; status: completed.
02
Drugs
epoetin thetaepoetin beta
03
Conditions
Uraemic Anaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-000142-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000142-37.